content top

30 Gauge Pars Plana Surgery in Recurrent Vitreous Hemorrhage: The Micro-invasive Technique

Advantage: Recurrent vitreous hemorrhage is common after vitrectomy which needs repeat surgery. Repeat intervention using standard technique is associated with considerable inflammatory response and delayed visual recovery that calls for a less invasive technique. The micro-invasive 30 gauge surgery for recurrent vitreous hemorrhage is safe, and effective. Methods: In this pilot study seven eyes of six patients underwent two-port 30...

Read More

Intravitreal Bevacizumab in Nanophthalmic Exudative Retinal Detachment

Satyen Deka, H Bhattacharjee, H Deka, M J Barman, S M Das (Guwahati, India) Advantages: Currently the only treatment option for exudative RD in nanophthalmic eye is surgical (Scleral Resection) with guarded visual prognosis. Intravitreal bevacizumab is a less invasive and safe treatment used for multiple retinal vascular/inflammatory diseases to treat the macular edema, the mode of action of which is through blockage of VEGF mediated...

Read More

Preoperative Intravitreal Bevacizumab in Diabetic Tractional Retinal Detachment

Satyen Deka, H Bhattacharjee, H Deka, M J Barman, R Saibum, S M Das (Guwahati, India) Advantages: Preoperative intravitreal bevacizumab in diabetic tractional retinal detachment (TRD) facilitates surgery, decreases the intraoperative bleeding and improves the visual acuity. Methods: In this non comparative interventional case series 10 eyes of 8 candidate diabetic TRD patients received 1.25 mg intravitreal off level bevacizumab 2-7 days...

Read More
content top